Company

About Altruist Biologics 

Altruist Biologics is a reliable, one-stop CDMO service provider, focusing on the development and commercial manufacturing of antibodies, fusion proteins, antibody drug conjugates, and other drugs. From cell line development to aseptic fill-finish, we are committed to supporting our clients develop affordable and high-quality biopharmaceuticals for the benefit of patients worldwide. 

Two scientists in lab coats and masks walking down a corridor carrying lab equipment

Our Mission & Vision

To help our global partners navigate the path from breakthrough science to life-changing treatment for patients through world-class development and manufacturing solutions.

Every molecule has a path forward.

OUR CORE VALUES 

Purpose-Driven Culture

To fully realize our mission, we have established a clear set of values that define our company and our culture.

Ethics & Integrity

We hold ourselves to the highest ethical standards, fostering trust through honesty, accountability, and open communication.

Collaboration & Inclusion

We champion teamwork, diversity, and mutual respect, empowering every voice to contribute to our collective success.

Innovation & Growth

We embrace a growth mindset, continuously improving and exploring new ways to deliver better outcomes for partners and patients.

Partner & Patient Centric

We place our clients and patients at the heart of all we do, striving to exceed expectations with tailored, high-quality solutions.

Safety & Excellence

We prioritize safety and world-class quality, ensuring that our services adhere to the most rigorous standards and regulations to protect and improve lives.

Sustainability

We act responsibly and sustainably, minimizing our environmental impact and contributing positively to the communities in which we operate.

Our History

An Innovent CDMO

Altruist is a wholly-owned subsidiary of Innovent Biologics, a leading biopharmaceutical company pioneering therapies that treat cancer - cardiovascular and metabolic - autoimmune and eye diseases. Since its founding in 2011, Innovent has launched 16 products in the market and has partnered with over 30 global healthcare companies.  

In 2022, Innovent Biologics Group established Altruist Biologics to provide fully integrated CDMO services. Today, Altruist continues to build on that legacy to support partners in improving global health through accessible development and manufacturing solutions.

Modern glass building facade with entrance surrounded by greenery in an urban setting.

Leadership

Meet The Executive Team 

We are guided by a strong leadership team of seasoned professionals with extensive experience in the pharmaceutical industry.

At a Glance

100+

Clinical & Commercial Products

2K+

Most Commercial Batches Produced in China

1.2K+

Highly Skilled Employees

232KL

Total Production Capacity

Aerial view of a modern office complex at night, illuminated buildings surrounded by green spaces and roads.
Several large stainless steel tanks in a well-lit, clean laboratory environment with overhead lighting.
Two technicians in blue uniforms and hairnets operating a computer in a large sterile industrial facility.

FACILITIES

Innovation by Design 

With a total capacity expected to reach 232,000 liters by 2026, our advanced GMP facilities ensure a stable and reliable supply of life-saving medicines to patients worldwide. 

  • Suzhou – Located at the heart of a global biomanufacturing hub, our Suzhou facility provides biologics development and clinical- and commercial-scale drug substance and drug product GMP manufacturing. 
  • Hangzhou – Our newest facility offers integrated development, large-scale manufacturing of bulk drug substance production with 4 x 20,000-liter bioreactors, and comprehensive drug product services.
Aerial view of a modern office complex at night, illuminated buildings surrounded by green spaces and roads.

QUALITY & COMPLIANCE 

World-Class Quality at Every Scale 

As a trusted CDMO provider, we are committed to delivering safe, reliable, and effective processes that meet global regulatory standards. 

Several large stainless steel tanks in a well-lit, clean laboratory environment with overhead lighting.

STRATEGIC PARTNERSHIPS

Building Mutual Trust

At Altruist Biologics, we recognize the power of collaboration in driving innovation and delivering best-in-class biologics to market. Our strategic alliances extend beyond transactional relationships; they are collaborative endeavors focused on mutual success. 

Here's what strategic alliances and partnerships mean for us:

  • Mutual Value Creation 
  • Complementary Capabilities 
  • Shared Risk & Reward 
  • Open Communication & Transparency 
  • Flexibility & Adaptability 
  • Ethical & Responsible Conduct
Two technicians in blue uniforms and hairnets operating a computer in a large sterile industrial facility.

Sustainability

Greener Together

Through our Environmental Management System, Altruist is engaging in environment-conscious practices to mitigate climate change risks in our operations and supply chains.

Sunrise over a vast field of solar panels stretching towards the horizon under a partly cloudy sky.
Scientist wearing lab coat and goggles working with pipette in laboratory setting with a colleague in the background

CAREERS

Work With Us 

We bring together the best and brightest minds to help us make a lasting impact. In a new era for human health, what we do has never mattered more as we tackle some of the industry’s biggest challenges to help our clients accelerate their life-saving therapies to patients. 

“Together, we’re supporting the production of life-changing therapies, and every person’s contribution drives impact for our partners and patients around the world. I firmly believe our success hinges on our people: when we embrace everyone’s unique strengths and support each other to thrive, we can truly make a difference.” 
-Dr. Kaisong Zhou, Chairman

Contact

Our Team is Your Team

Learn how we can achieve the success of your product from the early development stage, through the clinical lifecycle to commercialization and beyond.